| Literature DB >> 35593650 |
Chandrani Sarkar1,2,3,4,5, Debanjan Chakroborty1,2,3,4,5, Sandeep Goswami1,3,4, Hao Fan1, Xiaokui Mo6, Sujit Basu1,2,7.
Abstract
We have previously demonstrated significant upregulation of dopamine D2 (DAD2) receptor (DRD2) expression on tumor endothelial cells. The dopamine D2 receptors, upon activation, inhibit the proangiogenic actions of vascular endothelial growth factor-A (VEGF-A, also known as vascular permeability factor). Interestingly, unlike tumor endothelial cells, normal endothelial cells exhibit very low to no expression of dopamine D2 receptors. Here, for the first time, we demonstrate that through paracrine signaling, VEGF-A can control the expression of dopamine D2 receptors on endothelial cells via Krüppel-like factor 11 (KLF11)-extracellular signal-regulated kinase (ERK) 1/2 pathway. These results thus reveal a novel bidirectional communication between VEGF-A and DAD2 receptors.Entities:
Keywords: Dopamine D2 receptor; Endothelial cell; VEGF-A
Mesh:
Substances:
Year: 2022 PMID: 35593650 PMCID: PMC9234670 DOI: 10.1242/jcs.259617
Source DB: PubMed Journal: J Cell Sci ISSN: 0021-9533 Impact factor: 5.235